SRPT · Sarepta Therapeutics, Inc. · Share Buybacks
$18.22
-0.42 (-2.25%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$1.97B
Shares
105.63M
Volume · Sep 30
2M
Avg daily vol (3M)
3.07M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Remaining Authorization
$475,000,000
as of 2025-12-31
Program Utilization
5.0%
$25,000,000 used of $500,000,000
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-11-01 | $500,000,000 | — | — | — | 10-Q , filed 2026-05-06 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2025-12-31 | $25,013,000 | 10-K, filed 2026-03-02 | ||